From the lab bench to the factory floor

📍 Where we are: Part 9 of the journey — the recipe works in tiny flasks, and now we must make it work in giant tanks.

The scientists have a working recipe. They can grow the factory cells and make the antibody in small glass flasks. But a flask holds about 250 mL — less than a soda can. To make medicine for thousands of patients, we need tanks the size of a small car. Getting the recipe from tiny to huge is called scale-up, and handing it off to the factory is called tech transfer.

The simple version

Imagine your grandmother's cookie recipe. It is perfect when she bakes one tray in her kitchen. Now a factory wants to make one million cookies a day, all tasting exactly like hers. You cannot just multiply every number by a million and hope. A giant oven heats differently. A huge mixer stirs differently. You have to re-engineer the whole recipe for the big machines — and write it down so precisely that a stranger in another city bakes the identical cookie.

What actually happens

The living cells in a flask and in a giant tank face very different worlds. You cannot simply multiply the numbers, because three things change when the tank gets bigger:

1. Mixing. In a flask, every drop is the same. In a 2000 L tank, fresh food and oxygen take longer to reach every cell. Stir too gently and some cells starve; stir too hard and you hurt them.
2. Oxygen transfer. Cells breathe oxygen, just like we do. A big tank has much more liquid per surface area, so getting enough oxygen down to every cell is harder. Engineers must bubble gas in carefully.
3. Shear forces. Shear is the tearing drag a cell feels from fast-moving liquid and bubbles. Cells are delicate. Too much shear and they break apart. The bigger the tank, the trickier this balance.

Because of this, teams climb a ladder, testing the recipe at each rung before going bigger:

At pilot scale — a mid-size demonstration plant, such as NIIMBL's SABRE pilot facility — the team proves the recipe still works at, say, 200 L before risking a 2000 L tank.

First they do engineering runs: practice batches where the goal is to test the equipment and the steps, not to make sellable medicine. Mistakes here are cheap lessons. Once the practice runs are smooth, they switch to GMP runs. GMP stands for Good Manufacturing Practice — the strict, written-down rules that guarantee every batch is safe and identical. These GMP batches make the real material used in clinical trials, the carefully controlled studies that test the medicine in volunteers.

The other half of the job is tech transfer. The development team packages the entire validated process — the recipe, every parameter (temperature, stir speed, feed timing), the testing methods, and the exact materials — into a detailed manual and hands it to the manufacturing site. Done well, the factory reproduces the process exactly, the very first time.

Why it matters

If scale-up is rushed, the cells in the big tank behave differently from the flask. They might make less antibody, or make a slightly different antibody that the patient's body could react to. A weak tech transfer is just as dangerous: if a single parameter is written down wrong or left out, the factory batch can fail — wasting months and millions, or worse, putting an unsafe medicine on the path toward people. This step is the bridge where a promising science project becomes a real, repeatable, safe product.

In the real world

The standard commercial path scales up a fed-batch culture (cells fed in a closed tank) all the way to a 2000 to 20000 L stainless-steel tank — and scaling that big is genuinely hard.

A modern approach makes scale-up gentler. Facilities increasingly use single-use equipment (sterile plastic bags instead of giant steel tanks you must clean) and continuous processing, where smaller tanks run for a long time instead of one enormous one. With perfusion (fresh food flows in and product flows out continuously), a modest bioreactor can match a giant batch tank. This is the path the U.S. NIIMBL institute and its SABRE pilot facility are pioneering, and it can shrink the painful jump from pilot to commercial scale. You can read more about the standard recipe in process development and what comes next in the seed train.

Key terms

• Scale-up — re-engineering a process so it works in a much larger vessel, not just a small flask.
• Tech transfer — packaging a complete validated process and handing it to a manufacturing site to reproduce exactly.
• Pilot scale — a mid-size demonstration step between the lab and full commercial scale.
• Engineering run — a practice batch to test equipment and steps, not meant to make sellable medicine.
• GMP run — a batch made under Good Manufacturing Practice; produces real material, including for clinical trials.
• Shear force — the tearing drag from moving liquid and bubbles that can damage delicate cells.
• Single-use — sterile disposable plastic equipment used instead of cleaned steel tanks.
• Clinical trial — a controlled study that tests a medicine in volunteers.